Progenitor cell therapy of ischemic heart disease: the new frontier

ISSN： 1479-6678

Source： Future Cardiology, Vol.1, Iss.1, 2005-01, pp. : 87-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic Therapy for Ischemic Heart Disease: The Rationale for Inhibition of Fatty Acid Oxidation

By Stanley William Sabbah Hani

Heart Failure Reviews, Vol. 10, Iss. 4, 2005-12 ,pp. : 275-279

Springer Publishing Company

Access to resources Recommend Favorite

Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research

By Zhang Hao Wang Hong Li Na Duan Chang-En Yang Yue-Jin

Heart Failure Reviews, Vol. 19, Iss. 2, 2014-03 ,pp. : 247-258

Springer Publishing Company

Access to resources Recommend Favorite

Gender Differences in Ischemic Heart Disease

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 3, 2009-01 ,pp. : 234-240

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs and Ischemic Heart Disease: Towards a Better Comprehension of Pathogenesis, New Diagnostic Tools and New Therapeutic Targets

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 109-118

Bentham Science Publishers

Access to resources Recommend Favorite

Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells

By Rupp Stefan

Basic Research in Cardiology, Vol. 99, Iss. 1, 2004-01 ,pp. : 61-68

Springer Publishing Company

Access to resources Recommend Favorite